<DOC>
	<DOC>NCT00495183</DOC>
	<brief_summary>The aim of this study is to assess the efficacy of caffeine compared to placebo as a maintenance treatment for cocaine dependence. Caffeine potentiation with biperiden will be also studied. Ninety patients with snorted/sniffed cocaine dependence will be randomized to receive caffeine (300 - 1200 mg t.i.d.) plus biperidene (8 mg b.i.d.) caffeine (300 - 1200 mg t.i.d.) with placebo or placebo during 10 days in an in-hospital setting.</brief_summary>
	<brief_title>Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Biperiden</mesh_term>
	<mesh_term>Biperiden lactate</mesh_term>
	<criteria>diagnosis of cocaine dependence, according to DSMIVTR criteria age between 18 and 60 years current cocaine use, confirmed by a positive urine drug screen for cocaine the week prior to admission. demonstrated capacity to grant informed consent and sign the pertinent informed consent form. place of residence compatible with attendance at the center. for women, willingness to use effective contraceptive measures during the study. diagnosis of a severe medical disorder that could interfere with the study presence of an organic pathology for which methylxanthines or biperidene administration is contraindicated serum liver transaminase levels 3 times higher than normal values pregnancy and breastfeeding neuroleptic medication treatment in the past 6 weeks current treatment, or anticipation that the patient may need to initiate treatment during the study, with drugs that may interact with study medication. current diagnosis of a major mental disorder. awareness of a situation that could prevent the patient's participation in the study (e.g. serving a sentence) current participation in another research project.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>cocaine dependence</keyword>
	<keyword>cocaine use</keyword>
	<keyword>CNS stimulants</keyword>
	<keyword>caffeine</keyword>
	<keyword>biperiden</keyword>
	<keyword>placebo</keyword>
</DOC>